Literature DB >> 9055868

Engineering herpes simplex virus vectors for gene transfer to neurons.

D J Fink1, J C Glorioso.   

Abstract

HSV has a unique relationship with neurons which the virus naturally utilizes for efficient gene transfer and long-term gene expression. Progress in developing defective viral mutants with reduced cytotoxicity, and increasing insight into the state of the viral genome during latency and the functional elements of the latency promoter system, suggest that HSV vectors may be developed in which these natural features are exploited for effective transgene expression in brain.

Entities:  

Mesh:

Year:  1997        PMID: 9055868     DOI: 10.1038/nm0397-357

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  11 in total

1.  Engineering viral promoters for gene transfer to human neuroblasts.

Authors:  A Cara; E Lucarelli; P Cornaglia-Ferraris
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 3.  Gene therapy: novel treatments for polyneuropathy and chronic pain.

Authors:  Marina Mata; Joseph C Glorioso; David J Fink
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

Review 4.  Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

Authors:  Ronald J Mandel; Corinna Burger; Richard O Snyder
Journal:  Exp Neurol       Date:  2007-08-24       Impact factor: 5.330

Review 5.  Bioengineered probes for molecular magnetic resonance imaging in the nervous system.

Authors:  Vivian Hsieh; Alan Jasanoff
Journal:  ACS Chem Neurosci       Date:  2012-07-11       Impact factor: 4.418

6.  HIF1A overexpression using cell-penetrating DNA-binding protein induces angiogenesis in vitro and in vivo.

Authors:  Mijeong Jeon; Yooseok Shin; Jaeeun Jung; Ui-Won Jung; Jae-Hoon Lee; Jae-Seung Moon; Ilkoo Kim; Jin-Su Shin; Sang-Kyou Lee; Je Seon Song
Journal:  Mol Cell Biochem       Date:  2017-06-28       Impact factor: 3.396

Review 7.  Gene regulation and genetics in neurochemistry, past to future.

Authors:  Steven W Barger
Journal:  J Neurochem       Date:  2016-10-17       Impact factor: 5.372

8.  Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo.

Authors:  M Yamada; T Oligino; M Mata; J R Goss; J C Glorioso; D J Fink
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

9.  Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin.

Authors:  Hitoshi Yokoyama; Katsumi Sasaki; Michael E Franks; William F Goins; James R Goss; William C de Groat; Joseph C Glorioso; Michael B Chancellor; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2009-01       Impact factor: 5.695

10.  Gene therapy for Parkinson's disease.

Authors:  Rachel Denyer; Michael R Douglas
Journal:  Parkinsons Dis       Date:  2012-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.